Olistico Wealth’s AstraZeneca AZN Stock Holding History

Olistico Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.18K	Hold	44	–	–	﹤0.01%	289
2026 Q2	$8.23K	Buy	+44	New	+$8.28K	﹤0.01%	262
2026 Q1	–	Sell	-45	Closed	-$8.27K	–	344
2025 Q4	$8.27K	Buy	+45	New	+$7.89K	﹤0.01%	262
2025 Q3	–	Sell	-45	Closed	-$6.29K	–	111
2025 Q2	$6.29K	Buy	45 +32	+246%	+$4.48K	﹤0.01%	283
2025 Q1	$1.84K	Buy	13 +2	+18%	+$289	﹤0.01%	304
2024 Q4	$1.38K	Hold	11	–	–	﹤0.01%	291
2024 Q3	$1.64K	Hold	11	–	–	﹤0.01%	295
2024 Q2	$1.64K	Buy	+11	New	+$1.66K	﹤0.01%	288

Other funds holding AZN

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Olistico Wealth's AZN Position: Q3 2026 in Review

Olistico Wealth held its AstraZeneca (AZN) position steady in Q3 2026 at 44 shares worth $7.18K. The position accounts for ﹤0.01% of the portfolio, ranked #289.

Olistico Wealth first reported a position in AZN in Q2 2024 and has held it in 8 quarters since. The position peaked at $8.27K in Q4 2025. 918 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Olistico Wealth held 44 shares of AstraZeneca worth $7.18K as of Q3 2026.
Olistico Wealth left its AstraZeneca share count unchanged in Q3 2026.
AstraZeneca made up ﹤0.01% of Olistico Wealth's portfolio in Q3 2026, its #289 holding.
Olistico Wealth first reported a position in AstraZeneca in Q2 2024 and has held it in 8 quarters since.
Olistico Wealth's AstraZeneca position peaked at $8.27K in Q4 2025.
918 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Olistico Wealth's 13F filing for Q3 2026, filed 5 Oct 2026.